High materiality7/10
First Tracks Biotherapeutics price target raised to $65 from $48 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raised TRAX's target to $65 from $48. The posted price is $46.13, with priceChangeSinceSignal of -4.53.
- TRAX target raised to 65 from 48; price 46.13; -4.53 since signal.
Key facts
- 01
Target: $65
- 02
Posted price: $46.13
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.